deferasirox - Robuta Search

https://adisinsight.springer.com/drugsafety/803925336?error=cookies_not_supported&code=3049074e-591b-45be-bea0-ef438526fd37 Deferasirox - AdisInsight Children with acute leukaemia developed iron overload following multiple packed red blood cell transfusions and subsequently received deferasirox for iron deferasirox adisinsight https://pubmed.ncbi.nlm.nih.gov/28809446/ Deferasirox for managing iron overload in people with thalassaemia Deferasirox offers an important treatment option for people with thalassaemia and secondary iron overload. Based on the available data, deferasirox does not... iron overload deferasirox managing people thalassaemia https://pubs.rsc.org/en/content/articlelanding/2016/nj/c5nj02790j Deferasirox loaded on fumed silica nanoparticles used in cancer treatment - New Journal of... The present study has demonstrated a paradigm of successful in vitro drug delivery systems using Fumed Silica Nanoparticles (FSNPs) as a scaffold. The surface... https://pubmed.ncbi.nlm.nih.gov/35878782/ No difference in myocardial iron concentration and serum ferritin with deferasirox and deferiprone... Our analysis shows no significant difference between the efficacy of DFX and DFP in the management of iron overload in children with inherited blood disorders.... no difference https://adisinsight.springer.com/drugsafety/803043957?error=cookies_not_supported&code=5e61c5b1-3011-4b19-8e0c-3b12ec1fca8e Deferasirox - AdisInsight A 63-year-old woman with hereditary haemochromatosis developed liver injury during deferasirox therapy for iron overload.The woman received deferasirox 500mg deferasirox adisinsight https://adisinsight.springer.com/drugsafety/803487441?error=cookies_not_supported&code=926465b4-57c9-4954-b0a0-1fb32685a43b Deferasirox - AdisInsight A 29-year-old man developed gastrointestinal side effects during treatment with deferasirox for high liver iron concentration.The man presented with anaemia. He deferasirox adisinsight https://adisinsight.springer.com/drugsafety/803897937?error=cookies_not_supported&code=a37d34c1-a88b-45e3-ba75-e02fdd0026c1 Deferasirox - AdisInsight A 15-year-old girl developed hyperammonaemic hepatic encephalopathy during treatment with deferasirox for sickle-cell disease [duration of treatment to deferasirox adisinsight https://hq.imm.cnr.it/publications/disturbo-del-visus-paziente-affetto-da-talassemia-major-terapia-con-deferasirox Disturbo del visus in paziente affetto da talassemia major in terapia con Deferasirox | Catania HQ https://www.cochrane.org/ms/evidence/CD007461_deferasirox-managing-iron-overload-people-myelodysplastic-syndrome Deferasirox for managing iron overload in people with myelodysplastic syndrome | Cochrane iron overload myelodysplastic syndrome deferasirox managing